Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Operating Income (2022 - 2025)

CervoMed's Operating Income history spans 9 years, with the latest figure at -$8.0 million for Q3 2025.

  • For Q3 2025, Operating Income fell 49.07% year-over-year to -$8.0 million; the TTM value through Sep 2025 reached -$27.2 million, down 102.01%, while the annual FY2024 figure was -$18.2 million, 133.3% down from the prior year.
  • Operating Income for Q3 2025 was -$8.0 million at CervoMed, down from -$6.6 million in the prior quarter.
  • Across five years, Operating Income topped out at -$938823.0 in Q4 2022 and bottomed at -$8.0 million in Q3 2025.
  • The 4-year median for Operating Income is -$3.0 million (2024), against an average of -$3.9 million.
  • The largest annual shift saw Operating Income soared 68.68% in 2023 before it crashed 191.92% in 2024.
  • A 4-year view of Operating Income shows it stood at -$938823.0 in 2022, then plummeted by 164.21% to -$2.5 million in 2023, then plummeted by 191.92% to -$7.2 million in 2024, then fell by 11.1% to -$8.0 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Operating Income are -$8.0 million (Q3 2025), -$6.6 million (Q2 2025), and -$5.3 million (Q1 2025).